Select Publications
Journal articles
2024, 'The protocol for an observational Australian cohort study of CADASIL: The AusCADASIL study', Cerebral Circulation - Cognition and Behavior, 6, http://dx.doi.org/10.1016/j.cccb.2024.100225
,2023, 'Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial', Stroke, 54, pp. 2962 - 2971, http://dx.doi.org/10.1161/STROKEAHA.123.044568
,2021, 'Systemic lupus erythematosus presenting as Guillain-Barré syndrome', Practical Neurology, 21, pp. 237 - 240, http://dx.doi.org/10.1136/practneurol-2020-002849
,2020, 'Contrast-induced encephalopathy: A complication of coronary angiography', Practical Neurology, 20, pp. 482 - 485, http://dx.doi.org/10.1136/practneurol-2020-002524
,2020, 'Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial', The Lancet Neurology, 19, pp. 651 - 660, http://dx.doi.org/10.1016/S1474-4422(20)30207-6
,2019, 'Teaching Video NeuroImages: Tongue myokymia in hypoglossal neuropathy', Neurology, 93, pp. E214, http://dx.doi.org/10.1212/WNL.0000000000007756
,2019, 'Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke', New England Journal of Medicine, 380, pp. 1795 - 1803, http://dx.doi.org/10.1056/NEJMoa1813046
,2017, 'An unusual presentation of varicella zoster virus with acute cerebellitis and SIADH without a rash', Journal of Clinical Neuroscience, 41, pp. 90 - 91, http://dx.doi.org/10.1016/j.jocn.2017.03.007
,2017, 'Recurrent contrast-induced encephalopathy following coronary angiography', Internal Medicine Journal, 47, pp. 221 - 224, http://dx.doi.org/10.1111/imj.13321
,2016, 'Contrast-induced encephalopathy following cardiac catheterization', Catheterization and Cardiovascular Interventions, http://dx.doi.org/10.1002/ccd.26871
,2015, 'STroke imAging pRevention and treatment (START): A longitudinal stroke cohort study: Clinical trials protocol', International Journal of Stroke, 10, pp. 636 - 644, http://dx.doi.org/10.1111/ijs.12190
,2014, 'Percutaneous Left Atrial Appendage Occlusion with a Watchman Device Following Recurrent Stroke on Warfarin and Rivaroxaban in Patient with Paroxysmal Atrial Fibrillation', Heart Lung and Circulation, 23, pp. 171 - 173, http://dx.doi.org/10.1016/j.hlc.2013.08.013
,2014, 'The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): Protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial', International Journal of Stroke, 9, pp. 519 - 524, http://dx.doi.org/10.1111/ijs.12132
,2013, 'Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin', Annals of Neurology, 74, pp. 266 - 274, http://dx.doi.org/10.1002/ana.23924
,2013, 'The integrated model of therapy: Increasing therapy time in the Stroke Care Unit (SCU) - A protocol', INTERNATIONAL JOURNAL OF STROKE, 8, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327900900090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Endovascular therapy after intravenous t-PA versus t-PA alone for stroke', New England Journal of Medicine, 368, pp. 893 - 903, http://dx.doi.org/10.1056/NEJMoa1214300
,2013, 'Safety of intravenous thrombolysis for acute ischemic stroke in patients treated with warfarin', CEREBROVASCULAR DISEASES, 35, pp. 567 - 567, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329092602017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Intracranial Haemorrhagic Events with Continuous-Flow Centrifugal Left Ventricular Assist Devices: A Tertiary Centre Experience', Heart, Lung and Circulation, 22, pp. S205, http://dx.doi.org/10.1016/j.hlc.2013.05.487
,2013, 'STroke imAging pRevention and treatment (START): A longitudinal stroke cohort study: Clinical trials protocol', International Journal of Stroke, http://dx.doi.org/10.1111/ijs.12190
,2012, 'Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis', Heart Lung and Circulation, 21, pp. 853 - 855, http://dx.doi.org/10.1016/j.hlc.2012.06.003
,2012, 'A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)', International Journal of Stroke, 7, pp. 74 - 80, http://dx.doi.org/10.1111/j.1747-4949.2011.00730.x
,2012, 'Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy', Journal of Neurovirology, 18, pp. 264 - 276, http://dx.doi.org/10.1007/s13365-012-0092-3
,2011, 'Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: Report from a randomized, controlled trial', Stroke, 42, pp. 2229 - 2234, http://dx.doi.org/10.1161/STROKEAHA.111.613653
,2011, 'A study of 90-day outcomes for a cohort of patients admitted to an Australian metropolitan acute stroke unit', Journal of Vascular Nursing, 29, pp. 3 - 10, http://dx.doi.org/10.1016/j.jvn.2010.11.004
,2011, 'Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion', International Journal of Stroke, 6, pp. 87 - 89, http://dx.doi.org/10.1111/j.1747-4949.2010.00545.x
,2011, 'Fluctuating gustatory disturbance and ophthalmodynia heralding the onset of a paramedian pontine infarction.', Journal of Clinical Neuroscience, 18, pp. 983 - 985
,2010, 'Response to "A Graphic Reanalysis of the NINDS Trial"', Annals of Emergency Medicine, 55, pp. 227 - 229, http://dx.doi.org/10.1016/j.annemergmed.2009.09.026
,2010, 'Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and TIA', Internal Medicine Journal, 40, pp. 275 - 280, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19383060
,2010, 'Thrombolysis for acute stroke in Australia: Outcomes from the safe implementation of Thrombolysis in stroke registry (2002-2008)', , 193, pp. 439 - 443
,2009, 'Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke', Journal of Clinical Neuroscience, 16, pp. 178 - 187, http://dx.doi.org/10.1016/j.jocn.2008.04.002
,2008, 'Reply', Medical Journal of Australia, 188, pp. 489 - 490, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01732.x
,2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', Medical Journal of Australia, 188, pp. 489 - 490
,2007, 'Longitudinal prevalence and determinants of early mood disorder post-stroke', Journal of Clinical Neuroscience, 14, pp. 429 - 434, http://dx.doi.org/10.1016/j.jocn.2006.01.025
,2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, 187, pp. 567 - 570
,2006, 'Inflammation following stroke', Journal of Clinical Neuroscience, 13, pp. 1 - 8, http://dx.doi.org/10.1016/j.jocn.2005.07.005
,2005, 'Is white matter involved in patients entered into typical trials of neuroprotection?', Stroke, 36, pp. 2742 - 2744, http://dx.doi.org/10.1161/01.STR.0000189748.52500.a7
,2005, 'The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke', Stroke, 36, pp. 2132 - 2137, http://dx.doi.org/10.1161/01.STR.0000181066.23213.8f
,2004, 'The resistance to ischemia of white and gray matter after stroke', Annals of Neurology, 56, pp. 695 - 701, http://dx.doi.org/10.1002/ana.20265
,2004, 'MRI in ALS: Corticospinal tract hyperintensity [2] (multiple letters)', Neurology, 63, pp. 596 - 597, http://dx.doi.org/10.1212/WNL.63.3.596-a
,2004, 'Tissue plasminogen activator (tPA) in acute ischaemic stroke: Time for collegiate communication and consensus', Medical Journal of Australia, 180, pp. 634 - 636, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06127.x
,2004, 'Hypoxic tissue in ischaemic stroke: Persistence and clinical consequences of spontaneous survival', Brain, 127, pp. 1427 - 1436, http://dx.doi.org/10.1093/brain/awh162
,2004, 'Penumbral topography in human stroke: Methodology and validation of the 'Penumbragram'', NeuroImage, 21, pp. 1252 - 1259, http://dx.doi.org/10.1016/j.neuroimage.2003.11.020
,2004, 'Imaging the ischaemic penumbra', Current Opinion in Neurology, 17, pp. 61 - 67, http://dx.doi.org/10.1097/00019052-200402000-00011
,2003, 'MRI in ALS: Corticospinal tract hyperintensity', Neurology, 61, pp. 1600, http://dx.doi.org/10.1212/01.WNL.0000096015.48322.2A
,2003, 'Can the Time Window for Administration of Thrombolytics in Stroke be Increased?', CNS Drugs, 17, pp. 995 - 1011, http://dx.doi.org/10.2165/00023210-200317140-00001
,2003, 'Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-Fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke', Stroke, 34, pp. 2646 - 2652, http://dx.doi.org/10.1161/01.STR.0000094422.74023.FF
,2002, 'Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke', Stroke, 33, pp. 2236 - 2242, http://dx.doi.org/10.1161/01.STR.0000027859.59415.66
,2002, 'Salvaging the ischaemic penumbra: More than just reperfusion?', Clinical and Experimental Pharmacology and Physiology, 29, pp. 1 - 10, http://dx.doi.org/10.1046/j.1440-1681.2002.03609.x
,2002, 'Statistical parametric mapping of hypoxic tissue identified by [18F]fluoromisonidazole and positron emission tomography following acute ischemic stroke', NeuroImage, 16, pp. 425 - 433, http://dx.doi.org/10.1006/nimg.2002.1056
,2001, 'Early CT Changes Do Not Predict Parenchymal Haemorrhage Following Streptokinase Therapy In Acute Stroke.', Stroke, 32, pp. 370 - 371, http://dx.doi.org/10.1161/str.32.suppl_1.370-d
,